`571-272-7822 Date: June 30, 2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`
`
`BRECKENRIDGE PHARMACEUTICAL, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS AG,
`Patent Owner.
`
`____________
`
`Cases IPR2016-01023 and IPR2016-01103
`Patent 5,665,772
`____________
`
`
`
`Before LORA M. GREEN, CHRISTOPHER L. CRUMBLEY, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`CRUMBLEY, Administrative Patent Judge.
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`For the reasons set forth in our Order entered today in IPR2016-00084
`(Paper 22), it is hereby
`
`
`
`IPR2016-01023 and IPR2016-01103
`Patent 5,665,772
`
`
`ORDERED that in these proceedings, Novartis shall file its
`preliminary response to the Petitions, if any, on or before July 29, 2016.
`
`2
`
`
`
`
`
`IPR2016-01023 and IPR2016-01103
`Patent 5,665,772
`
`FOR PETITIONER:
`
`B. Jefferson Boggs
`Matthew L. Fedowitz
`Daniel R. Evans
`MERCHANT & GOULD P.C.
`jboggs@merchantgould.com
`mfedowitz@merchantgould.com
`devans@merchantgould.com
`
`FOR PATENT OWNER:
`
`Nicholas N. Kallas
`Raymond Mandra
`FITZPATRICK, CELLA, HARPER & SCINTO
`nkallas@fchs.com
`rmandra@fchs.com
`
`3